Greenwich LifeSciences, Inc.·4

Jan 3, 6:05 AM ET

Patel Snehal 4

4 · Greenwich LifeSciences, Inc. · Filed Jan 3, 2025

Insider Transaction Report

Form 4
Period: 2024-12-31
Patel Snehal
DirectorCEO and CFO10% Owner
Transactions
  • Purchase

    Common Stock

    2024-12-31$11.36/sh+2,400$27,2645,541,702 total

Documents

1 file
  • 4
    ownership.xmlPrimary